Microfluidic Perfusable Pathological Vasculature for Atherosclerosis Drug Screening.

Research (Wash D C) · 2025 · PMC12446761 · PMID 40979559

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

In addition, the fluorescence areas of both SMCs and GFP-HUVECs showed an increasing trend (Fig. 4 B), indicating that GelMA provided a supportive environment for SMC growth and EC attachment.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.